These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3056818)

  • 1. Human proinsulin. Does it improve the treatment of type I diabetics?
    Landgraf-Leurs MM; Hörmann R; Loy A; König A; Kammerer S; Landgraf R
    Horm Metab Res Suppl; 1988; 18():83-9. PubMed ID: 3056818
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical investigations into the modification of the effect of endogenous and exogenous insulin by human proinsulin in type II and type I diabetics.
    Bellenberg S; Schröder KE; Schlüter KJ; Bottermann P; Zilker T; Gray P
    Horm Metab Res Suppl; 1988; 18():77-83. PubMed ID: 3056817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the prolonged hypoglycemic effect of human proinsulin in diabetes mellitus.
    Laube H; Pinter W; Federlin K
    Horm Metab Res Suppl; 1988; 18():12-5. PubMed ID: 3056806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of human proinsulin on blood glucose control and metabolic instability in type 1 diabetes mellitus.
    Bock E; Quabbe HJ
    Diabetes Res; 1989 Apr; 10(4):165-9. PubMed ID: 2692943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substitution of basal delivery of insulin by proinsulin in type I diabetic patients under CSII.
    Kerner W; Wallmüller G; Beischer W; Pfeiffer EF
    Horm Metab Res Suppl; 1988; 18():74-7. PubMed ID: 3056816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic effects of biosynthetic human proinsulin in individuals with type I diabetes.
    Bergenstal RM; Cohen RM; Lever E; Polonsky K; Jaspan J; Blix PM; Revers R; Olefsky JM; Kolterman O; Steiner K
    J Clin Endocrinol Metab; 1984 Jun; 58(6):973-9. PubMed ID: 6373814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with human proinsulin in eighteen patients with type I and type II diabetes mellitus.
    Thomas VA; Lamberton RP; Krauss DS; Kahn CB
    R I Med J (1976); 1991 Oct; 74(10):463-8. PubMed ID: 1957115
    [No Abstract]   [Full Text] [Related]  

  • 8. Human proinsulin in insulin-treated juvenile diabetics.
    Heding LG; Ludvigsson J
    Acta Paediatr Scand Suppl; 1977; (270):48-52. PubMed ID: 278468
    [No Abstract]   [Full Text] [Related]  

  • 9. Effectiveness of treatment of insulin-dependent diabetes with single dose of mixture of three kinds of insulin, employing semisynthetic human insulin.
    Quatraro A; Consoli G; Magno M; Ceriello A; Giugliano D
    Diabete Metab; 1989; 15(3):147-8. PubMed ID: 2668056
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic aspects of human proinsulin therapy.
    Fineberg SE; Rathbun MJ; Hufferd S; Fineberg NS; Spradlin CT; Galloway JA; Frank BH
    Diabetes; 1988 Mar; 37(3):276-80. PubMed ID: 3286327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixing insulin lispro and ultralente insulin.
    Bastyr EJ; Holcombe JH; Anderson JH; Clore JN
    Diabetes Care; 1997 Jun; 20(6):1047-8. PubMed ID: 9167130
    [No Abstract]   [Full Text] [Related]  

  • 12. Proinsulin level in diabetes mellitus measured by a new immunochemiluminometric assay.
    Wu TJ; Lin CL; Taylor RL; Kao PC
    Ann Clin Lab Sci; 1995; 25(6):467-74. PubMed ID: 8572555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration of porcine proinsulin-like material in plasma of insulin-treated diabetics in relation to purity of insulin preparations.
    Aaby P
    Horm Metab Res; 1979 Aug; 11(8):455-7. PubMed ID: 574119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glycosylated blood proteins in diabetes mellitus].
    Germaniuk IaL
    Klin Med (Mosk); 1982 Oct; 60(10):17-21. PubMed ID: 6757559
    [No Abstract]   [Full Text] [Related]  

  • 15. Intensified insulin therapy.
    Amiel SA
    Diabetes Metab Rev; 1993 Apr; 9(1):3-24. PubMed ID: 8344121
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA).
    Müller-Esch G; von der Lühe C; Ball P; Henkel E; Schlüter KJ; Wood WG; Scriba PC
    Horm Metab Res Suppl; 1988; 18():24-33. PubMed ID: 2847967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cotherapy with recombinant human IGF-I and insulin improves glycemic control in type 1 diabetes.
    Lanzetta P; Malara C
    Diabetes Care; 2000 Mar; 23(3):436-7. PubMed ID: 10868894
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic effects of combination glipizide and human proinsulin treatment in NIDDM.
    Pasmantier R; Chaiken RL; Hirsch SR; Lebovitz HE
    Diabetes Care; 1990 Aug; 13 Suppl 3():42-6. PubMed ID: 2209343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus and pregnancy: management simplified by a computer assisted home glucose meter and measurement of glycosylated protein.
    Moses RG
    Asia Oceania J Obstet Gynaecol; 1987 Jun; 13(2):127-30. PubMed ID: 3632457
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization and Oral Delivery of Proinsulin-Transferrin Fusion Protein Expressed Using ExpressTec.
    Chen YS; Zaro JL; Zhang D; Huang N; Simon A; Shen WC
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29373562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.